Skip to search formSkip to main contentSkip to account menu

Lymphoid leukemia

Known as: LEUKEMIA LYMPHOID, lymphoid leukaemia, Lymphocytic Leukemias 
A malignant lymphocytic neoplasm of B-cell or T-cell lineage involving primarily the bone marrow and the peripheral blood. This category includes… 
National Institutes of Health

Related topics

Related topics

37 relations
Acute lymphocytic leukemiaAggressive natural killer-cell leukemiaAtypical lymphocyteBCL10 gene

Narrower (4)

Chronic Lymphocytic LeukemiaLeukemia, Lymphocytic, Acute, L2Lymphoid Leukemia in RemissionSubacute lymphatic leukemia

Broader (2)

Neoplasmsleukemia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
MicroRNAs: novel biomarkers for human cancer.
BACKGROUND MicroRNAs (miRNAs), small RNA molecules of approximately 22 nucleotides, have been shown to be up- or downregulated in… 
Highly Cited
2005
Highly Cited
2005
The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia.
Activating mutations in tyrosine kinases have been identified in hematopoietic and nonhematopoietic malignancies. Recently, we… 
Review
2004
Review
2004
Development of the Proteasome Inhibitor Velcade™ (Bortezomib)
The dipeptide boronic acid analogue VELCADE™ (Bortezomib; formerly known as PS-341, LDP-341 and MLM341) is a potent and selective… 
Highly Cited
2001
Highly Cited
2001
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity.
PURPOSE Rituximab has been reported to have little activity in small lymphocytic lymphoma (SLL)/chronic lymphocytic leukemia (CLL… 
Highly Cited
1997
Highly Cited
1997
Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia.
Translocations in hematologic disease of myeloid or lymphoid origin with breakpoints at chromosome band 12p13 frequently result… 
Highly Cited
1989
Highly Cited
1989
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.
To assess the influence of graft-versus-host disease (GVHD) on recurrent leukemia and survival after allogeneic marrow… 
Highly Cited
1988
Highly Cited
1988
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.
The Philadelphia chromosome is present in more than 95% of chronic myeloid leukemia patients and 13% of acute lymphocytic… 
Highly Cited
1987
Highly Cited
1987
Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen
Busulfan 16 mg/kg and cyclophosphamide 120 mg/kg were used as conditioning prior to allogeneic marrow transplantation in 50 adult… 
Review
1975
Review
1975
New approaches to the classification of the lymphomata.
Our recently proposed functional approach to and classification of the malignant lymphomata based upon the T and B cell systems… 
Highly Cited
1973
Highly Cited
1973
Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.
Lymphocytes that bind in vitro to sheep erythrocytes in a rosette formation are thymus-derived. A modified technique that does… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)